We are building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. We are utilizing our proprietary FORCE platform to overcome the current limitations of muscle tissue delivery and advance modern oligonucleotide therapeutics for muscle diseases. Using our FORCE platform, we are assembling a broad portfolio […]

While we may pursue an initial business combination in any industry, we intend to focus our efforts on businesses that leverage our management team’s experience in acquiring and operating businesses in the consumer (“Consumer”) as well as technology, media and telecommunications (“TMT”) industries. We intend to focus our efforts and will seek to capitalize on […]

(Note: This is not a traditional IPO. This is a direct listing of Palantir’s Class A common stock on the New York Stock Exchange without the involvement of underwriters. From the prospectus: “We have engaged Morgan Stanley & Co. LLC (“Morgan Stanley”), Credit Suisse Securities (USA) LLC, Goldman Sachs & Co. LLC, Allen & Company […]

Good Works Acquisition Corp. is a newly organized blank check company. We intend to initially focus our search on identifying a prospective target business that has experienced financial distress or has recently emerged from a financial restructuring. Our name, Good Works, embodies our secondary objective. Our company, through three of our officers and directors, has […]

  We are a newly organized blank check company. While we may pursue an initial business combination with a company in any sector, we intend to focus our search on the consumer sector and consumer-related businesses, which complements the expertise of our management team, directors and advisors. Ken Suslow is the CEO and chairman. Designer […]

  We are a global private markets investment firm focused on providing customized investment solutions and advisory and data services to our clients. Our clients include some of the world’s largest public and private defined benefit and defined contribution pension funds, sovereign wealth funds and insurance companies, as well as prominent endowments, foundations, family offices […]

  We are a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal, or GI, diseases. Our most advanced program targets the farnesoid X receptor, or FXR, which is central to modulating liver and GI diseases. FXR agonism has been investigated in large-scale clinical trials and has shown clinically […]

Our mission is to democratize access to education in Brazil through a digital ecosystem and empower every student to create their own success story. Postsecondary education students in Brazil have been facing several challenges, including (1) high tuition fees with few to no financing alternatives, (2) long commutes, (3) lack of access to continuously available resources for studying, […]

We believe in a data connected world where organizations have seamless access to explore, share, and unlock the value of data. To realize this vision, we are pioneering the Data Cloud, an ecosystem where Snowflake customers, partners, and data providers can break down data silos and derive value from rapidly growing data sets in secure, […]

  We provide an end-to-end, hybrid, universal DevOps Platform to achieve CSRM. Our leading CSRM platform enables organizations to continuously deliver software updates across any system. Our platform is the critical bridge between software development and deployment of that software, paving the way for the modern DevOps paradigm. We enable organizations to build and release […]